홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /화합물

Triflusal

HCID 9458
새 반응
인쇄
기본 정보개요이름 및 식별자물성안전 및 규제화학 및 산업관련 반응화합물 노트
부분 구조 검색유사 구조 찾기

기본 정보

CAS
322-79-2
표준 SMILES
CC(=O)Oc1cc(C(F)(F)F)ccc1C(=O)O
InChIKey
RMWVZGDJPAKBDE-UHFFFAOYSA-N
분자식
C10H7F3O4
평균 분자량
248.15 g/mol
단동위원소 질량
248.02964319

개요

2-acetyloxy-4-(trifluoromethyl)benzoic acid is a member of benzoic acids, a member of salicylates and a carboxylic ester.

이름 및 식별자

우선 이름
Triflusal
IUPAC
2-acetyloxy-4-(trifluoromethyl)benzoic acid
영어명
Triflusal
분자식
C10H7F3O4
분자량
248.16

이름 및 동의어

Triflusal322-79-22-Acetoxy-4-trifluoromethylbenzoic acid2-(Acetyloxy)-4-(trifluoromethyl)benzoic acidTriflusalumDTXSID80453051Z0YFI05OODTXCID6025305RefChem:191611B01AC18206-297-5Disgren
이름 더 보기
ur1501DrisgenTriflusal-d3Triflusal CRSTriflusal (UR1501)TRIFLUOROTRIMESICACIDTriflusal, 10 mM in DMSO4-trifluoromethylsalicylicacidacetate
2-Acetoxy-4-(trifluoromethyl)benzoic Acid2-acetyloxy-4-(trifluoromethyl)benzoic acidAflenTriflusal [INN]MFCD00866793TrifluxBenzoic acid, 2-(acetyloxy)-4-(trifluoromethyl)-Prestwick1_000528

데이터베이스 식별자

CAS
322-79-2
PubChem CID
9458
DTXSID
DTXSID8045305
ChEMBL
CHEMBL1332032
ChEBI
CHEBI:94721
UNII
1Z0YFI05OO
EC Number
206-297-5
Nikkaji
J5.672C

물성

구조 계산 물성

XLogP
2.1
극성 표면적
63.6 Ų
수소 결합 공여자 수
1
수소 결합 수용자 수
7
회전 가능 결합 수
3
무거운 원자 수
17
형식 전하
0
복잡도
313

실험 및 물리화학적 성질

Drugs · 2건

Pharmaceuticals -> Listed in ZINC15

Pharmaceuticals -> Blood and blood forming organs -> Antithrombotic agents

Solubility<1 mg/ml
Melting Point114-117ºC

물리화학적 성질

녹는점
120 · 120-122° (upon slow heating); 110-112° (upon quick heating)
끓는 점
316 · 316.0±42.0 °C(Predicted)
밀도
1.433 · 1.433±0.06 g/cm3(Predicted)
저장 조건
2 · Sealed in dry,2-8°C
용해도
30 mg/mL · DMSO: >30mg/mL
산도 계수 (pKa)
2.97 · 2.97±0.10(Predicted)
물리적 상태
가루
색상
흰색에서 황백색까지
Merck
14 · 14,9688
InChI
1S/C10H7F3O4/c1-5(14)17-8-4-6(10(11,12)13)2-3-7(8)9(15)16/h2-4H,1H3,(H,15,16)
InChIKey
RMWVZGDJPAKBDE-UHFFFAOYSA-N
SMILES

안전 및 규제

안전 정보는 참고용이며, 공급업체의 물질안전보건자료(SDS), 관련 법규 및 전문가 평가를 대체하지 않습니다.

GHS 분류

GHS Classification · 4건

Warning

H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]

P261, P264, P264+P265, P270, P271, P272, P280, P301+P317, P302+P352, P304+P340, P305+P351+P338, P319, P321, P330, P332+P317, P333+P317, P337+P317, P362+P364, P403+P233, P405, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 44 reports by companies from 6 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

유해성 정보

Hazard Classes and CategoriesAcute Tox. 4 (100%)

안전 데이터

wgk
3
rtecs
GP4250000
HS 번호
2918.29.7500
risk_code
22-36/37/38-43
hazard_code
Xn
safety_code
26-36/37
Hazard Classifications
Acute Tox. 4 OralEye Irrit. 2Skin Irrit. 2Skin Sens. 1STOT SE 3
스토리지 클래스
11 - Combustible Solids

화학 및 산업

약리 정보

ATC Code · 2건

B - Blood and blood forming organs

QB - Blood and blood forming organs

Protein BindingTriflusal binds almost completely to plasma proteins reaching a 99% of the administered dose.
Pharmacodynamics · 1건

Triflusal is an antithrombotic anticoagulant. It irreversibly inhibits the production of thromboxane-B2 in platelets by acetylating cycloxygenase-1. Triflusal affects many other targets such as NF kappa B, which is a gene expression regulatory factor for cycloxygenase-a and cytokines. Numerous studies comparing the efficacy and safety profile (i.e. systemic hemorrhage) between triflusal and acetylsalsylic acid has shown either no significant difference or a better effacy and safety profile for triflusal. Triflusal has been shown to protect cerebral tissue due to its inhibition of lipid peroxidation resulting from anoxia-reoxygenation.

Mechanism of Action · 1건

Triflusal is chemically related to acetylsalicylic acid (ASA) and irreversibly inhibits cycloxygenase-1 (COX-1) in platelets. Acetylation of the active group of COX-1 prevents the formation of thromboxane-B2 in platelets. However, it is unique because it spares the arachidonic acid metabolic pathway in endothelial cells. In addition, it favors the production of nitric oxide, a vasodilator.

Biological Half-LifeIn the healthy human, the half-life is 0.5 +/- 0.1h, while that of HTB is 34.3 +/- 5.3h.
Metabolism/MetabolitesIn the liver, triflusal undergoes deacetylation, forming its main metabolite 2-OH-4-trifluoromethyl benzoic acid (HTB). This major metabolite seems to have marked antiplatelet properties in vitro.
MeSH Pharmacological Classification · 1건

Drugs or agents which antagonize or impair any mechanism leading to blood platelet aggregation, whether during the phases of activation and shape change or following the dense-granule release reaction and stimulation of the prostaglandin-thromboxane system.

관련 반응

2건
반응 기록 만들기
HRID 98027 반응식
HRID 98027반응물로
HRID 1038770 반응식
HRID 1038770반응물로

화합물 노트

이 페이지에서기본 정보개요이름 및 식별자물성안전 및 규제화학 및 산업관련 반응화합물 노트
FC(F)(F)c1cc(c(cc1)C(=O)O)OC(=O)C

화학적 성질

White to Off-White Solid

Absorption, Distribution and Excretion · 4건

Absorbed in the small intestine with a bioavailability range from 83% to 100%. There is no significant difference between the absorption of the oral solution and capsule formulation. Triflusal displays a Cmax of 11.6 mcg/ml and a tmax of 0.88 h. The major metabolite of triflusal presents different pharmacokinetic properties by showing a Cmax and tmax of 92.7 mcg/ml and 4.96 h, respectively.

The elimination pathway of triflusal is primarily renal. Urine analysis has shown the presence of unchanged triflusal, HTB and the glycine conjugate of HTB.

The reported volume of distribution for triflusal is of 34L.

Renal clearance is 0.8 +/- 0.2L/h and 0.18 +/1 0.04L/h for triflusal and HTB, respectively.

응용 분야

용도An analog of Aspirin; inhibits platelet aggregation. Antithrombotic.

상·하류 제품 정보

하류 제품

아세테이트4-Trifluoromethylsalicylic acid